PL3363428T3 - Perfuzyjna postać dawkowania - Google Patents

Perfuzyjna postać dawkowania

Info

Publication number
PL3363428T3
PL3363428T3 PL18162403.2T PL18162403T PL3363428T3 PL 3363428 T3 PL3363428 T3 PL 3363428T3 PL 18162403 T PL18162403 T PL 18162403T PL 3363428 T3 PL3363428 T3 PL 3363428T3
Authority
PL
Poland
Prior art keywords
dosage form
perfusion dosage
perfusion
dosage
Prior art date
Application number
PL18162403.2T
Other languages
English (en)
Inventor
Kumar SAMARTH
Kane PRASHANT
Bhowmich Subhas BALARAM
Ganorkar Kirti
Patel Nishit
Dubewar Ashish Anilrao
Patel Umeshkumar Mukeshbhai
Original Assignee
Sun Pharmaceutical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sun Pharmaceutical Industries Ltd filed Critical Sun Pharmaceutical Industries Ltd
Publication of PL3363428T3 publication Critical patent/PL3363428T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/05Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
    • A61J1/10Bag-type containers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14Details; Accessories therefor
    • A61J1/16Holders for containers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/4738Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/1407Infusion of two or more substances
    • A61M5/1408Infusion of two or more substances in parallel, e.g. manifolds, sequencing valves
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B65CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65BMACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
    • B65B55/00Preserving, protecting or purifying packages or package contents in association with packaging
    • B65B55/02Sterilising, e.g. of complete packages
    • B65B55/04Sterilising wrappers or receptacles prior to, or during, packaging
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B65CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65DCONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D81/00Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents
    • B65D81/24Adaptations for preventing deterioration or decay of contents; Applications to the container or packaging material of food preservatives, fungicides, pesticides or animal repellants
    • B65D81/26Adaptations for preventing deterioration or decay of contents; Applications to the container or packaging material of food preservatives, fungicides, pesticides or animal repellants with provision for draining away, or absorbing, or removing by ventilation, fluids, e.g. exuded by contents; Applications of corrosion inhibitors or desiccators
    • B65D81/266Adaptations for preventing deterioration or decay of contents; Applications to the container or packaging material of food preservatives, fungicides, pesticides or animal repellants with provision for draining away, or absorbing, or removing by ventilation, fluids, e.g. exuded by contents; Applications of corrosion inhibitors or desiccators for absorbing gases, e.g. oxygen absorbers or desiccants
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G16H20/13ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered from dispensers
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G16H20/17ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16ZINFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS, NOT OTHERWISE PROVIDED FOR
    • G16Z99/00Subject matter not provided for in other main groups of this subclass

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Medical Informatics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Primary Health Care (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mechanical Engineering (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Food Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PL18162403.2T 2014-09-03 2015-09-03 Perfuzyjna postać dawkowania PL3363428T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN2804MU2014 2014-09-03

Publications (1)

Publication Number Publication Date
PL3363428T3 true PL3363428T3 (pl) 2024-06-10

Family

ID=54106163

Family Applications (1)

Application Number Title Priority Date Filing Date
PL18162403.2T PL3363428T3 (pl) 2014-09-03 2015-09-03 Perfuzyjna postać dawkowania

Country Status (9)

Country Link
US (3) US10098813B2 (pl)
EP (3) EP4368175A3 (pl)
JP (4) JP2016093480A (pl)
KR (1) KR102584402B1 (pl)
DK (1) DK3363428T3 (pl)
ES (1) ES2985740T3 (pl)
FI (1) FI3363428T3 (pl)
PL (1) PL3363428T3 (pl)
TW (2) TWI769126B (pl)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10098813B2 (en) * 2014-09-03 2018-10-16 Sun Pharmaceutical Industries Limited Perfusion dosage form
JP6612763B2 (ja) * 2014-10-02 2019-11-27 テルモ株式会社 タンパク質溶液製剤を収容するための医療用容器
FI4011377T3 (fi) * 2015-02-13 2025-01-07 Sun Pharmaceutical Ind Ltd Suonensisäinen infuusioannosmuoto sisältäen pemetreksediä
PL3413862T3 (pl) 2016-02-09 2024-03-18 Sun Pharmaceutical Industries Ltd. Układ perfuzyjny
US10369077B2 (en) * 2017-05-31 2019-08-06 Adienne Pharma & Biotech Sa Multi chamber flexible bag and methods of using the same
US10507165B2 (en) * 2017-05-31 2019-12-17 Adienne Pharma & Biotech Sa Multi chamber flexible bag and methods of using same
US20190105262A1 (en) * 2017-10-10 2019-04-11 Sun Pharmaceutical Industries Ltd. Intravenous infusion dosage form for pemetrexed
KR102632686B1 (ko) * 2018-09-24 2024-02-02 오 파마슈티컬 컴퍼니 리미티드 주입 시스템
CN111498207B (zh) 2019-01-30 2023-05-02 百特国际有限公司 医用流体容器制备系统和方法
CN113543769A (zh) 2019-02-22 2021-10-22 太阳医药工业有限公司 用于静脉内使用的咪达唑仑的输注袋
EP4023202A1 (en) * 2020-12-29 2022-07-06 B. Braun Melsungen AG Medicinal product comprising a flexible plastic bag and an aqueous, ready-to-use solution of midazolam

Family Cites Families (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4447230A (en) * 1981-08-05 1984-05-08 Quest Medical, Inc. Intravenous administration set assembly
JPS62221352A (ja) * 1986-03-22 1987-09-29 株式会社新素材総合研究所 酸素による薬液の変質を防止する薬液入りプラスチック容器の製造方法
DE4336336A1 (de) 1992-11-23 1994-05-26 Lang Volker Kasetteninfusionssystem
US5786344A (en) 1994-07-05 1998-07-28 Arch Development Corporation Camptothecin drug combinations and methods with reduced side effects
US5896989A (en) * 1998-02-20 1999-04-27 Bracco Research Usa Flexible medical container packaging
US6771697B1 (en) 1998-06-23 2004-08-03 Pctel, Inc. Spread spectrum handshake for digital subscriber line telecommunications systems
US7235583B1 (en) 1999-03-09 2007-06-26 Luitpold Pharmaceuticals, Inc., Fatty acid-anticancer conjugates and uses thereof
AU4564200A (en) 1999-04-29 2000-11-17 Aventis Pharma S.A. Method for treating cancer using camptothecin derivatives and 5-fluorouracil
US7243689B2 (en) 2000-02-11 2007-07-17 Medical Instill Technologies, Inc. Device with needle penetrable and laser resealable portion and related method
CA2408710C (en) 2000-05-15 2010-01-26 Celgene Corp. Compositions and methods for the treatment of colorectal cancer
US7352770B1 (en) 2000-08-04 2008-04-01 Intellon Corporation Media access control protocol with priority and contention-free intervals
JP2002073810A (ja) * 2000-08-31 2002-03-12 Terumo Corp 輸液剤組成解析プログラム及びこれを用いた輸液剤処方サポートシステム
US20050137971A1 (en) 2000-10-02 2005-06-23 Ibm Corporation Personally customizable credit card accounts
US20030039306A1 (en) 2001-04-06 2003-02-27 Redfern Arthur John Low peak-to-average ratio quiescent mode architecture and signal design method for DMT modems
US20030031240A1 (en) 2001-07-31 2003-02-13 Redfern Arthur J. Downstream only suspend-type Q-Mode
US6936413B1 (en) * 2001-12-05 2005-08-30 Baxter International Inc. Methods and systems for preparing blood products
US6476068B1 (en) * 2001-12-06 2002-11-05 Pharmacia Italia, S.P.A. Platinum derivative pharmaceutical formulations
US7122210B2 (en) * 2002-01-11 2006-10-17 Baxter International Inc. Bicarbonate-based solutions for dialysis therapies
EP2546152A3 (en) 2002-09-03 2014-03-26 Medical Instill Technologies, Inc. Sealed containers and methods of making and filling same
JP4787455B2 (ja) 2002-12-12 2011-10-05 テルモ株式会社 ビタミンb1類含有水性製剤充填済み容器体を収容した包装体
ES2528669T3 (es) * 2003-04-08 2015-02-11 Progenics Pharmaceuticals, Inc. Formulaciones farmacéuticas que contienen metilnaltrexona
MY141763A (en) 2003-09-18 2010-06-30 Novartis Ag Pharmaceutical products comprising bisphosphonates
US20080242691A1 (en) 2004-02-13 2008-10-02 Kabushiki Kaisha Yakult Honsha Aqueous Solution Preparation Containing Camptothecins
CN101128230B (zh) * 2005-02-11 2010-09-29 麻省理工学院 表面注射装置
JP2006248978A (ja) * 2005-03-10 2006-09-21 Mebiopharm Co Ltd 新規なリポソーム製剤
JP2010503696A (ja) 2006-09-13 2010-02-04 ヌベロ, インコーポレイテッド 癌を処置するための方法
US20110177161A1 (en) 2007-05-24 2011-07-21 Dr. Reddy's Laboratories Limited Pharmaceutical compositions of [5(s)-(2'-hydroxyethoxy)-20(s)-camptothecin
EP2259776A4 (en) 2008-02-29 2011-03-16 Eagle Pharmaceuticals Inc USEFUL TOPOTECAN SOLUTIONS
WO2009130564A1 (en) * 2008-04-22 2009-10-29 Fidia Farmaceutici S.P.A. Therapeutic use of new pharmaceutical preparations containing antitumoral drugs bound to hyaluronic acid in the treatment of neoplasias
RU2496499C2 (ru) 2008-09-26 2013-10-27 Эститю Де Кансероложи Де Л'Вест Оптимизация индивидуальных доз 5-фторурацила при режиме folfiri
WO2010088973A1 (en) * 2009-02-06 2010-08-12 Shl Group Ab Medicament delivery device with electronic dose sensor
EP2954913A1 (en) * 2009-06-24 2015-12-16 Carticept Medical, Inc. Injection system for delivering multiple fluids within the anatomy
KR20120111721A (ko) 2009-07-01 2012-10-10 프레제니우스 메디칼 케어 홀딩스 인코퍼레이티드 약물 전달 장치와 이에 관련된 시스템 및 방법
SI2508170T1 (sl) * 2009-12-03 2015-12-31 Jiangsu Hengrui Medicine Co., Ltd. Liposom z irinotekanom ali njegovim hidrokloridom in njun postopek priprave
JP2011250726A (ja) 2010-06-01 2011-12-15 Toyo Kohan Co Ltd イリノテカンの副作用の発生危険度を判定する方法及びそのためのキット
AR085215A1 (es) 2011-02-15 2013-09-18 Sanofi Aventis Deutschland Interfaz de dispensacion para uso con un dispositivo dispensador de farmacos que libera dos o mas agentes farmaceuticos
WO2012177798A2 (en) 2011-06-20 2012-12-27 Renaudia Medical, Llc Distributed medication delivery system and method having autonomous delivery devices
AU2012339701B8 (en) * 2011-11-15 2017-11-16 Allergan, Inc. Autoclavable suspensions of cyclosporin A Form 2
WO2013171763A1 (en) * 2012-04-27 2013-11-21 Sun Pharmaceutical Industries Ltd Ready to be infused gemcitabine solution
RU2015100517A (ru) 2012-06-13 2016-08-10 ДР. ПИ ИНСТИТЬЮТ ЭлЭлСи Устройство, имеющее протыкаемую перегородку, заполняющую иглу и протыкаемую крышку, и связанный с ним способ
US9125805B2 (en) 2012-06-27 2015-09-08 Xeris Pharmaceuticals, Inc. Stable formulations for parenteral injection of small molecule drugs
CN102824345B (zh) * 2012-09-20 2014-03-26 江苏奥赛康药业股份有限公司 一种盐酸伊立替康组合物及其制备方法
CN102885765B (zh) * 2012-10-25 2013-11-06 哈药集团生物工程有限公司 一种盐酸伊立替康注射液及其制备方法
CN103989624B (zh) * 2013-02-20 2018-04-27 中国科学院上海药物研究所 一种盐酸伊立替康组合物及其制备方法
EP3021811A1 (en) * 2013-07-15 2016-05-25 Alchemia Oncology Pty Limited Method of pre-preparing medications for therapeutic uses
US10098813B2 (en) * 2014-09-03 2018-10-16 Sun Pharmaceutical Industries Limited Perfusion dosage form
PL3413862T3 (pl) 2016-02-09 2024-03-18 Sun Pharmaceutical Industries Ltd. Układ perfuzyjny

Also Published As

Publication number Publication date
EP4368175A2 (en) 2024-05-15
DK3363428T3 (da) 2024-05-21
KR102584402B1 (ko) 2023-10-04
EP2992869A1 (en) 2016-03-09
JP2024088701A (ja) 2024-07-02
US11793719B2 (en) 2023-10-24
FI3363428T3 (fi) 2024-05-10
JP2021038223A (ja) 2021-03-11
JP2016093480A (ja) 2016-05-26
KR20160028401A (ko) 2016-03-11
EP4368175A3 (en) 2024-07-17
ES2985740T3 (es) 2024-11-07
US20190046398A1 (en) 2019-02-14
US10098813B2 (en) 2018-10-16
US20160058663A1 (en) 2016-03-03
TWI769126B (zh) 2022-07-01
EP3363428B1 (en) 2024-02-14
EP3363428A1 (en) 2018-08-22
US20230087099A1 (en) 2023-03-23
JP2022062078A (ja) 2022-04-19
JP7029510B2 (ja) 2022-03-03
TWI860522B (zh) 2024-11-01
TW201625194A (zh) 2016-07-16
JP7466579B2 (ja) 2024-04-12
TW202245728A (zh) 2022-12-01

Similar Documents

Publication Publication Date Title
IL270954A (en) Pharmaceutical compounds
GB201419579D0 (en) Pharmaceutical compound
GB201414730D0 (en) Pharmaceutical compound
GB201404922D0 (en) Pharmaceutical compounds
PL3363428T3 (pl) Perfuzyjna postać dawkowania
GB201416513D0 (en) Pharmaceutical compounds
IL247084B (en) dose fgh–18
GB201417707D0 (en) Pharmaceutical compounds
GB201418710D0 (en) Dosage regimen
TWM488998U (en) Syringe
SG11201704819WA (en) Syringe
GB201406115D0 (en) New pharmaceutical use
IL249374A0 (en) Pharmaceutical administration forms
GB201409662D0 (en) New pharmaceutical use
GB201508022D0 (en) Pharmaceutical compounds
GB201418708D0 (en) Dosage regimen
GB201416968D0 (en) Pharmaceutical compounds
GB201416969D0 (en) Pharmaceutical compounds
GB201416625D0 (en) Pharmaceutical compounds
GB201416627D0 (en) Pharmaceutical compounds
GB201416622D0 (en) Pharmaceutical compounds
GB201411148D0 (en) New pharmaceutical uses
GB201400171D0 (en) Dosage regimen
GB201419570D0 (en) Pharmaceutical compound
GB201404896D0 (en) Pharmaceutical compounds